The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma- Dynamics of Quality of Life
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1510
https://www.valueinhealthjournal.com/article/S1098-3015(17)31844-2/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1363
First Page :
A649
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31844-2&doi=10.1016/j.jval.2017.08.1510